Improving the situation of people affected by breathlessness

Our third Newsletter is now available!

Find out more about the what we have achieved in the last six months, how COVID-19 has impacted our project and our mission and what we are working on at the moment.

You can find the full newsletter here.

Newsletter03_preview

← Return

Click here to subscribe to our newsletter

News

Practice review: Pharmacological management of severe chronic breathlessness in adults with advanced life-limiting diseases

13 Sep Category: General

We are very pleased to announce the publication of a Practice review 'Pharmacological management of severe chronic breathlessness in adults with advanced life-limiting diseases'. The review provides practice recommendations on the safe use of pharmacological therapies for severe chronic breathlessness. Please go to the publications page to view.

BETTER-B trial results published in The Lancet Respiratory Medicine

09 Sep Category: General

We are delighted that the BETTER-B trial results are now published by The Lancet Respiratory Medicine . To find out more about the trial results, please go to the BETTER-B trial results page in the project menu.

Patient, Carer, Clinician and Policy briefs on BETTER-B trial findings

09 Sep Category: General

We have developed a summary of our findings and recommendations from the BETTER-B trial in briefs targeted at patients, carers, clinicians and policy makers. Please see the home page and project menu to access the briefs.

2024 European Respiratory Society (ERS) Congress

09 Sep Category: General

Professor Irene Higginson will be presenting findings from the BETTER-B trial as part of the Clinical Trials session: ALERT 2: Fighting the burden of asthma and respiratory symptoms. The session at the European Respiratory Society (ERS) Congress in Vienna runs today, Monday 9 September from 1530-1700 (local time).

Page 1 of 13> >>

Tweets by CSI_KCL

Next page: Project